Effect of unani medicine in patients with Eczema
Phase 3
- Conditions
- Health Condition 1: L208- Other atopic dermatitis
- Registration Number
- CTRI/2023/11/060053
- Lead Sponsor
- Dr Syeda Mariya Hassan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Both sex
Itching
Erythema
Scaling
Exclusion Criteria
1 Any systemic illness
2 Pregnant and lactating
and others
3 Mentally retarded patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome depend on relief of itching as per Eczema Area Severity IndexTimepoint: O <br/ ><br>10th day <br/ ><br>20th day <br/ ><br>30th day
- Secondary Outcome Measures
Name Time Method Primary outcome depend on relief of itching as per Eczema Area Severity IndexTimepoint: It can be assess with in a period of 30 days